DailyIQ
Last updated1 minute ago

MET·MetLife, Inc.

$100.27
+0.55 (+0.55%)
Overnight$100.05-0.22 (-0.22%)
High
$100.62
Open
$100.24
Market Cap
63.14B
52W High
$101.44
Low
$98.59
P. Close
$100.27
P/E
17.41
52W Low
$67.33
Fwd P/E
8.99
DailyIQ Est.
$110.24
Inst. Ownership
32.7%
Short Interest
1.79%
Days to Cover
3.3
Div. Yield
2.32%
Next Ex-Div
~Nov 3
Div. Growth
12+ yrs
Technical Score (1D)
64
BULLISH
News Sentiment
54
MIXED
MET is setting up for a potential resolution: BUY at 64 with firm momentum on the 1D chart. Sentiment at 54 is diverging from the bullish bias, so confirmation still matters. $104.25 is the line bulls need to clear; $96.23 defines the risk if the attempt stalls. Momentum-driven buyers tend to show up only after $104.25 actually breaks, which means the setup can look identical for days before anything changes on the tape. That's the nature of breakout-watch conditions: the BUY read and firm momentum describe the pressure building, not the timing of when it releases.
LOW TARGET
$84 -16.0%
1 analysts
MEAN TARGET
$107 +7.3%
16 analysts
HIGH TARGET
$119 +18.9%
9 analysts
PRICE RANGE
$84.00 - $119.00
SB / B / H / S / SS
5/12/7/1/1
DAILYIQ EST.
$110.24 (+10.2%)
Sector
Financial Services
Industry
Insurance - Life
Exchange
NYQ
Country
United States
Symbol
MET
Description
MetLife, Inc. is a global financial services provider specializing in insurance, annuities, employee benefits, and asset management. The company serves a diverse international clientele through six primary operating segments, offering a wide array of products and services. Its core offerings include various life, health, and disability insurance plans, alongside retirement solutions such as annuities and pension risk transfers. MetLife also provides employee benefit programs and asset management services, catering to both individual and institutional clients. Incorporated in 1999 and headquartered in New York, the company’s extensive product portfolio and global reach position it as a significant player in the financial services sector.
Bought (1Y)
0 shares
$0
Sold (1Y)
39,795 shares
$3.5M
Kennard William E-
Award/Grant544 shares2026-10-01
HUBBARD ROBERT GLENN-
Award/Grant941 shares2026-10-01
Glaser Daniel S-
Award/Grant544 shares2026-10-01
Hay Laura J-
Award/Grant544 shares2026-10-01
Seitz Michelle-
Award/Grant544 shares2026-10-01
67/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Net Margin
138.7%
Revenue CAGR
-15.2%
Debt / Equity
0.85x
Return on Equity
11.9%
Earnings Summary
MetLife, Inc. is a global financial services provider specializing in insurance, annuities, employee benefits, and asset management, operating through six primary segments that serve a diverse international clientele. The company’s core offerings include life, health, and disability insurance plans, retirement solutions such as annuities and pension risk transfers, and employee benefit programs, positioning it as a significant player in the life‑insurance sector of the broader financial services industry. In the most recent quarter, MetLife reported Q4 2025 earnings with an EPS of $2.58, surpassing the estimate of $2.3656, while revenue reached $24.19 billion against an estimate of $28.00 billion, reflecting a decline in top‑line growth relative to prior periods. The company’s Q1 2026 EPS of $2.42 beat the $2.26912 estimate, and revenue of $19.68 billion narrowly exceeded the $19.42 billion estimate, indicating a modest acceleration in earnings momentum after a slight revenue dip in Q2 2025. Over the last four quarters, MetLife has consistently delivered EPS that meets or exceeds analyst expectations, with the most recent quarter marking the fourth consecutive beat, while revenue growth has slowed from a 4.5% increase in Q3 2025 to a 1.8% decline in Q4 2025, suggesting a deceleration in top‑line expansion. Historically, the company has maintained a steady YoY revenue growth trajectory of roughly 3–4% over the past three years, with EPS growth outpacing revenue in the most recent quarters, a pattern that underscores disciplined cost management and pricing power. Recent news highlights include the announcement of a fourth‑quarter 2026 common stock dividend of $0.5925 per share, reinforcing MetLife’s commitment to shareholder returns, and a partnership with Charm Industrial to mitigate wildfire risk, reflecting the insurer’s focus on emerging risk areas.

EPS

EstBeatMiss
$1.91$2.15$2.39$2.63$2.87Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$2.76 - -
Q2'26$2.32$2.43+4.9%
Q1'26$2.27$2.42+6.6%
Q4'25$2.37$2.58+9.1%
Q3'25$2.32$2.37+2.2%
Q2'25$2.16$2.02-6.7%

Revenue

EstBeatMiss
$16.4B$19.7B$23.0B$26.2B$29.5BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$20.0B - -
Q2'26$19.9B$19.1B-4.2%
Q1'26$19.4B$19.7B+1.3%
Q4'25$28.0B$24.2B-13.6%
Q3'25 - $17.9B -
Q2'25 - $17.9B -

Market Data

MET Stock Snapshot

NEUTRAL64/100
$100.05−$0.22 (0.2%)
Market cap
63.14B
P/E ratio
17.4
Day range
$98.59 – $100.62
News sentiment
54/100 · Neutral
Analyst target
$107.38 (+7.3%)
Consensus
Buy · 26 analysts
52-week range+48.6% off low · -1.4% from high
$67.33$101.44
Price $100.05 DailyIQ Est. $110.24

MET sits near its 52-week high with the technical picture unresolved. Earnings and guidance carry more weight than macro data at this capitalisation.

Behaviour On Record

What MET's own history says about today's numbers

Realized volatility (21d)
20.0% 35th pct
Below its peak
-0.5%
vs 200-day average
+18.8%
Up days (1y)
51%

MetLife, Inc. is currently running 20.0% annualised volatility over the last 21 sessions. Measured against MET's own 13 years of daily returns rather than a market-wide average, that is the 35th percentile — on the quiet side for this stock, against a typical reading of 23.0%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

MET is trading -0.5% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -20.2%, and the deepest was -55.3% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits +18.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 93rd percentile — a wider gap than this stock usually carries. Over the past year MET closed higher on 51% of sessions, and it is currently 1 session into a rising streak.

On October specifically: over 14 years of records, MET finished the month higher 9 of 14 times, with a median return of +1.9% and an average of +1.5%. Its strongest month historically has been November at +5.3% on average, its weakest March at -3.4%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: MET has opened more than 2% away from the prior close in 110 of 3,268 sessions (3.4% of the time), with the largest gaps running +5.9% and -8.3%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, MET moved an average of 2.8% in the session after earnings, closing higher 1 of those 3 times, with a median move of -2.0% and a largest of +3.8%.

All figures computed from 3,269 daily closes between 2013-10-16 and 2026-10-15, split-adjusted, recomputed daily. Percentiles are against MET's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of MET's sector?

MetLife, Inc. sits in the Financials sector, currently ranked 10th of 12 GICS sectors by relative-strength rotation score (improving). Within its narrower Insurance industry group, MET ranks 8th of 15 tracked industries, improving.

Sector rank
#10 of 12
Sector state
Improving
Sector rotation score
36
Industry rank
#8 of 15

Options Market

What is the options market pricing for MET?

CallsPuts

For MetLife, Inc.'s nearest expiry (2026-10-16, 0 days out), open interest is roughly balanced between puts and calls (put/call ratio of 1.12), with at-the-money implied volatility around 31.3%.

Put/call ratio (2026-10-16)
1.12
ATM implied volatility
31.3%
Total open interest
7,604

Analyst Rating Changes

Are analysts turning bullish or bearish on MET?

JP Morgan most recently reiterated its rating on MetLife, Inc. to Overweight on Oct 15, 2026 with a price target of $110 (from $108). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.

Latest action
JP Morgan — Overweight
90-day upgrades
1
90-day downgrades
0
Net rating momentum
+1
DateFirmActionRatingPrice target
Oct 15, 2026JP MorganMaintainedOverweight$108 → $110
Oct 12, 2026Wells FargoMaintainedOverweight$109 → $110
Oct 7, 2026MizuhoMaintainedOutperform$112 → $109
Oct 7, 2026BarclaysMaintainedOverweight$97 → $111
Oct 6, 2026UBSMaintainedBuy$105 → $110
Oct 5, 2026TD CowenMaintainedBuy$105 → $110
Sep 22, 2026Piper SandlerUpgradeNeutral → Overweight$99 → $110
Aug 24, 2026Morgan StanleyMaintainedOverweight$103 → $111
Aug 19, 2026Wells FargoMaintainedOverweight$101 → $109
Aug 11, 2026JP MorganMaintainedOverweight$106 → $108
Aug 11, 2026Keefe, Bruyette & WoodsMaintainedOutperform$105 → $108
Aug 6, 2026BarclaysMaintainedOverweight$94 → $97

Peers & ETF holders

MET peers & ETF holders

News Sentiment Analysis

Sentiment gathered from recent headlines

54/100
Strong NegativeNeutralStrong Positive
MIXED

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Wells Fargo analyst Wesley Carmichael upgraded MetLife to an Overweight rating on October 12, raising the price target from $109 to $110. The move reflects confidence in the insurer’s earnings outlook and its competitive positioning in the life‑insurance market. The upgrade signals a modest bullish stance, suggesting potential upside for investors. No immediate catalysts were cited beyond the analyst’s assessment of the company’s fundamentals.
What did this article say?
MetLife’s three series of listed preferred shares include two fixed‑coupon series that currently yield around 7%. The shares trade at discounts that offset call risk but remain highly sensitive to Treasury yield movements. Analysts rate the preferreds as hold, noting that price declines are likely if rates rise further. The high-yield premium reflects broader market rate increases rather than mispricing, making the risk/reward balance delicate for new investors. Overall, the preferreds are suitable for long‑term, income‑focused investors willing to tolerate price volatility.
What did this article say?
MetLife released the full transcript of its second‑quarter 2026 earnings conference call on October 8. The company discussed its financial performance for the period, outlining key metrics and operational highlights. Management addressed investor questions regarding revenue trends, expense management, and future outlook. The call provided stakeholders with detailed commentary on the company’s strategic priorities and risk factors. No material surprises or guidance changes were disclosed during the session.
What did this article say?
MetLife, Inc. scheduled the release of its third quarter 2026 financial results for November 4, 2026, following the market close. The company will also host an earnings conference call on November 5, 2026, from 9-10 a.m. ET, with a live webcast and a seven‑day replay available on its Investor Relations site. The announcement provides standard disclosure of upcoming earnings and related materials, with no indication of material changes to guidance or performance.
What did this article say?
Mizuho analyst Yaron Kinar kept MetLife on an Outperform rating but reduced the price target from $112 to $109. The downgrade reflects a more cautious view of the insurer’s earnings outlook amid rising claims and competitive pressures. The adjustment signals a modest negative shift in the firm’s valuation expectations for the near term.
What did this article say?
Mizuho Securities revised its price target for MetLife (MET) down to $109 from $112, reflecting a modest downgrade in the firm’s outlook. The adjustment was made while maintaining an overweight rating and an average target of $108.93 across analysts. The change indicates a slight concern about MetLife’s near‑term earnings or valuation relative to peers, but does not suggest a material shift in fundamentals.
What did this article say?
Barclays analyst Alex Scott upgraded MetLife to an Overweight rating and increased the price target from $97 to $111, signaling confidence in the company's prospects. The upgrade reflects expectations of continued growth in the insurance sector and favorable market conditions.
What did this article say?
MetLife announced that its board of directors had declared a fourth‑quarter 2026 common stock dividend of $0.5925 per share. The dividend was scheduled to be paid on December 8, 2026, to shareholders of record as of November 3, 2026. The declaration was issued as part of the company’s ongoing dividend policy and reflected its financial stability. No material changes to guidance or operations were disclosed.
What did this article say?
MetLife and CNP expressed interest in acquiring Prudential Financial’s Brazil and Mexico businesses, a move that could generate about $3 billion for Prudential. The potential transaction is expected to be announced this year, though the bidders and terms may still change. Neither MetLife nor CNP provided comments on the report, and the deal remains speculative at this stage.
What did this article say?
MetLife announced a partnership with Charm Industrial to reduce wildfire risk and provide benefits protection for Charm employees. The collaboration aims to support local jobs and enhance financial security for workers in wildfire‑prone areas. MetLife’s involvement is positioned as a community‑focused initiative that aligns with its broader mission of improving well‑being worldwide. The deal does not represent a major financial transaction but signals a strategic move into climate‑related risk management.

Technical Analysis

Real-time indicators across multiple timeframes

64
BULLISH
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $16.88B combined position · 13 adding, 12 trimming, 0 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
Vanguard Group Inc▲ Buy72,555,33511.57%$5.73B2026-01-29
BlackRock, Inc.▲ Buy51,786,9258.26%$4.38B2026-08-07
Geode Capital Management, LLC▲ Buy13,309,8842.12%$1.14B2026-08-12
Morgan Stanley▲ Buy12,532,0972.00%$1.06B2026-08-13
Invesco Ltd.▲ Buy6,929,7941.10%$586.33M2026-08-14
Norges Bank▼ Sell6,819,6571.09%$577.01M2026-08-12
Goldman Sachs Group Inc▲ Buy6,626,4351.06%$560.66M2026-08-14
Northern Trust Corp▼ Sell6,302,7681.00%$533.28M2026-08-13
Bank of America Corp▼ Sell5,382,6300.86%$455.42M2026-08-14
JPMorgan Chase & Co▲ Buy4,101,0290.65%$352.65M2026-08-12
AQR Capital Management LLC▲ Buy4,122,3330.66%$348.79M2026-08-14
Wellington Management Group LLP▼ Sell3,404,4950.54%$288.05M2026-08-14
FMR LLC (Fidelity)▲ Buy1,968,3250.31%$166.54M2026-08-13
Prudential Financial Inc▼ Sell1,595,1940.25%$134.97M2026-08-12
Wells Fargo & Company▼ Sell1,450,5110.23%$122.73M2026-08-14
Man Group plc▼ Sell1,223,6680.20%$103.53M2026-08-14
Citigroup Inc▼ Sell997,4810.16%$84.40M2026-08-03
Citadel Advisors LLC▼ Sell872,3410.14%$73.81M2026-09-02
Bridgewater Associates, LP▼ Sell621,5190.10%$52.59M2026-08-14
AllianceBernstein L.P.▲ Buy737,7710.12%$52.18M2026-08-14
Neuberger Berman Group LLC▼ Sell217,6170.03%$18.41M2026-08-13
Susquehanna International Group, LLP▲ Buy200,3980.03%$16.96M2026-08-14
Millennium Management LLC▼ Sell188,2530.03%$15.93M2026-08-14
D. E. Shaw & Co., Inc.▲ Buy184,3260.03%$15.60M2026-08-14
Gotham Asset Management, LLC▲ Buy175,7890.03%$14.87M2026-08-14
Q2 2026 flow:3.76M sh bought ($319.17M)4.36M sh sold ($369.30M)net -602.0K sh (−$50.13M)
Congressional Trading Activity
12 disclosed trades · ~$230.0K est. traded value · 6 buys, 6 sells
MemberChamberStateTypeAmountTradedFiled
Alan ArmstrongSenateOK▲ Buy$1K - $15K2026-03-272026-07-21
Gilbert CisnerosHouseCA31▼ Sell$1K - $15K2025-08-062025-09-12
Ritchie John TorresHouseNY15▼ Sell$1K - $15K2025-07-112025-08-20
Sheldon WhitehouseSenateRI▼ Sell$1K - $15K2024-11-192024-12-05
Sheldon WhitehouseSenateRI▼ Sell$1K - $15K2023-09-202023-10-17
John HoevenSenateND▲ Buy$50K - $100K2019-03-222019-04-09
John HoevenSenateND▲ Buy$50K - $100K2018-06-072018-06-14
Patty MurraySenateWA▼ Sell$1K - $15K2017-06-152017-06-22
Patty MurraySenateWA▲ Buy$1K - $15K2017-03-162017-03-21
Sheldon WhitehouseSenateRI▲ Buy$1K - $15K2016-08-182016-09-09
Sheldon WhitehouseSenateRI▲ Buy$1K - $15K2016-03-242016-04-04
Susan M. CollinsSenateME▼ Sell$1K - $15K2014-11-102014-12-01